3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
60
Central Nervous System Neoplasms
39
Brain Neoplasms
34
Medulloblastoma
26
Astrocytoma
15
Rhabdoid Tumor
12
Glioblastoma
12
Ependymoma
12
Sarcoma
10
Glioma
9
Testicular Neoplasms
8
Oligodendroglioma
7
Choroid Plexus Neoplasms
7
Teratoma
6
Optic Nerve Glioma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Gliosarcoma
6
Testicular Germ Cell Tumor
5
Retinoblastoma
5
Neuroectodermal Tumors, Primitive
5
Neoplasms
5
Lymphoma
5
Recurrence
4
Ovarian Neoplasms
4
Ganglioneuroblastoma
4
Familial ependymoma
4
Carcinoma, Renal Cell
4
Spinal Cord Neoplasms
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Interventions
Cancer Vaccines
2
Adjuvants, Immunologic
2
veliparib
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
Trastuzumab
1
Tissue Banks
1
Modafinil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nervous System Neoplasms
×
Etoposide
×
CNS
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled